NCT00002078View on ClinicalTrials.gov

Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Interferon alfa-n3

Trial Locations (2)

20307

Walter Reed Army Institute of Research, Washington D.C.

20889

Natl Naval Med Ctr, Bethesda

All Listed Sponsors
collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

collaborator

Henry M. Jackson Foundation for the Advancement of Military Medicine

OTHER

lead

Purdue Frederick

INDUSTRY

NCT00002078 - Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection | Biotech Hunter | Biotech Hunter